Salerno Pharms patent expiration

1. Flolipid patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10300041 SALERNO PHARMS Liquid oral simvastatin compositions
Apr, 2027

(2 years from now)

US9597289 SALERNO PHARMS Liquid oral simvastatin compositions
Feb, 2030

(5 years from now)




Drugs and Companies using SIMVASTATIN ingredient

Market Authorisation Date: 21 April, 2016

Treatment: NA

Dosage: SUSPENSION

More Information on Dosage

FLOLIPID family patents

Family Patents